CurrentCardio
Get Weekly

Topic · page 38 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,481–1,520 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. J Am Coll Cardiol

    Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program

    Secondary analysis

  2. JACC Heart Fail

    Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics

    Randomised controlled trial

  3. Eur J Heart Fail

    Contemporary Guideline-Directed Medical Therapy in De Novo, Chronic, and Worsening Heart Failure Patients: First Data from the TITRATE-HF Study

    Cohort study

  4. JACC Heart Fail

    Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk

    Secondary analysis

  5. JACC Heart Fail

    Diuresis Efficacy in Ambulatory Congested Heart Failure Patients: Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF)

    Randomised controlled trial

  6. Eur J Heart Fail

    New York Heart Association Functional Class and Implantable Cardioverter-Defibrillator in Non-Ischaemic Heart Failure with Reduced Ejection Fraction: Extended Follow-Up of the DANISH Trial

    Secondary analysis

  7. Eur J Heart Fail

    Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial

    Randomised controlled trial

  8. Eur J Heart Fail

    Sacubitril/Valsartan and Cardiovascular Biomarkers Among Patients with Recent COVID-19 Infection: The PARACOR-19 Randomized Clinical Trial

    Randomised controlled trial

  9. J Am Coll Cardiol

    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

    Guideline or statement

  10. Circulation

    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

    Guideline or statement

  11. Eur J Heart Fail

    Echocardiographic Predictors of Cardiovascular Outcome in Heart Failure with Preserved Ejection Fraction

    Meta-analysis

  12. JACC Heart Fail

    Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices: The DOAC LVAD Study

    Randomised controlled trial

  13. Eur J Heart Fail

    Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

    Meta-analysis

  14. Eur J Heart Fail

    Use of Medical Therapy and Risk of Clinical Events According to Frailty in Heart Failure Patients – A Real-Life Cohort Study

    Cohort study

  15. Eur J Heart Fail

    Identification and Outcomes of KDIGO-Defined Chronic Kidney Disease in 1.4 Million U.S. Veterans with Heart Failure

    Cohort study

  16. Eur J Heart Fail

    Sex Differences in the Prognostic Role of Achieving Target Doses of Heart Failure Medications: Data from the Swedish Heart Failure Registry

    Cohort study

  17. JACC Heart Fail

    Cost-Effectiveness of Medical Therapy for Heart Failure With Mildly Reduced and Preserved Ejection Fraction

    Research article

  18. JAMA Cardiol

    Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction

    Diagnostic or prognostic study

  19. JACC CardioOncol

    Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid Cardiomyopathy

    Secondary analysis

  20. J Am Coll Cardiol

    Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Cohort study

  21. Eur J Heart Fail

    Randomized Investigation of the MitraClip Device in Heart Failure: Design and Rationale of the RESHAPE-HF2 Trial Design

    Trial design

  22. JAMA

    Differences in Donor Heart Acceptance by Race and Gender of Patients on the Transplant Waiting List

    Cohort study

  23. Eur J Heart Fail

    A Roadmap for Therapeutic Discovery in Pulmonary Hypertension Associated with Left Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function

    Guideline or statement

  24. JACC Heart Fail

    Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial

    Secondary analysis

  25. JACC Heart Fail

    Impact of Insurance Status and Region on Angiotensin Receptor–Neprilysin Inhibitor Prescription During Heart Failure Hospitalizations

    Cohort study

  26. Eur J Heart Fail

    Long-Term Efficacy and Safety of Tailored Immunosuppressive Therapy in Immune-Mediated Biopsy-Proven Myocarditis: A Propensity-Weighted Study

    Cohort study

  27. JACC CardioOncol

    Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin Lymphoma

    Cohort study

  28. Eur J Heart Fail

    Reporting Quality of Heart Failure Randomized Controlled Trials 2000–2020: Temporal Trends in Adherence to CONSORT Criteria

    Meta-analysis

  29. Eur J Heart Fail

    Serum Metabolomics Improves Risk Stratification for Incident Heart Failure

    Cohort study

  30. J Am Coll Cardiol

    Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure

    Randomised controlled trial

  31. Eur J Heart Fail

    Dietary Sodium and Fluid Intake in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC

    Guideline or statement

  32. Eur J Heart Fail

    Cause-Specific Death in Heart Failure Across the Ejection Fraction Spectrum: A Comprehensive Assessment of Over 100 000 Patients in the Swedish Heart Failure Registry

    Cohort study

  33. Eur J Heart Fail

    Impact of Guideline-Directed Medical Therapy on Systolic Blood Pressure and Cardiovascular Outcomes in Patients with Heart Failure and Low Blood Pressure: A Systematic Review and Meta-Analysis

    Meta-analysis

  34. Eur J Heart Fail

    Baroreflex Activation Therapy in Patients with Heart Failure and a Reduced Ejection Fraction: Long-Term Outcomes

    Randomised controlled trial

  35. Eur J Heart Fail

    N-Terminal Pro-B-Type Natriuretic Peptide Post-Discharge Monitoring in the Management of Patients with Heart Failure and Preserved Ejection Fraction – A Randomized Trial: The NICE Study

    Randomised controlled trial

  36. JACC Heart Fail

    Public Reporting of Heart Transplant Center Performance: Promoting Clarity or Causing Confusion?

    Cohort study

  37. JACC Cardiovasc Imaging

    Cardiovascular Magnetic Resonance Reference Ranges From the Healthy Hearts Consortium

    Cross-sectional study

  38. Eur Heart J

    Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry

    Cohort study

  39. J Am Coll Cardiol

    Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure

    Randomised controlled trial

  40. J Am Coll Cardiol

    Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy

    Randomised controlled trial

All 1,928 Briefs in ExploreShowing Briefs 1,481–1,520 of 1,928, newest first